2023 Q2 Form 10-K Financial Statement

#000149315223012515 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $1.765M $1.857M $6.454M
YoY Change 15.68% 684.52% 1310.16%
Cost Of Revenue $1.322M $1.357M $5.435M
YoY Change -3.52% 547.7% 1208.39%
Gross Profit $442.7K $499.5K $1.019M
YoY Change 185.36% 1741.63% 2309.98%
Gross Profit Margin 25.08% 26.9% 15.79%
Selling, General & Admin $496.8K $582.9K $2.062M
YoY Change -5.55% -26.19% 16.08%
% of Gross Profit 112.24% 116.7% 202.37%
Research & Development $0.00 $1.800K
YoY Change
% of Gross Profit 0.0% 0.18%
Depreciation & Amortization $3.470K $19.03K $159.1K
YoY Change -94.26% -72.26% -42.05%
% of Gross Profit 0.78% 3.81% 15.61%
Operating Expenses $496.8K $582.9K $2.062M
YoY Change -5.55% -26.19% 16.08%
Operating Profit -$54.18K -$83.42K -$1.043M
YoY Change -85.39% -89.06% -39.85%
Interest Expense -$1.450K -$18.28K -$61.53K
YoY Change -86.26% 112.06% 432.27%
% of Operating Profit
Other Income/Expense, Net $976.5K $190.00 -$61.33K
YoY Change -9365.82% -98.47% -786.77%
Pretax Income $922.3K -$101.5K -$1.104M
YoY Change -341.78% -86.62% -36.41%
Income Tax $0.00
% Of Pretax Income
Net Earnings $922.3K -$128.0K -$1.103M
YoY Change -379.31% -83.2% -36.6%
Net Earnings / Revenue 52.25% -6.9% -17.09%
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 333.6M shares 148.0M shares 158.0M shares
Diluted Shares Outstanding 333.6M shares 158.0M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $127.1K $264.8K $264.8K
YoY Change -5.8% 183.09% 183.09%
Cash & Equivalents $127.1K $264.8K
Short-Term Investments
Other Short-Term Assets $1.142M $435.8K $490.8K
YoY Change 187.84% -11.86% -0.74%
Inventory
Prepaid Expenses $226.6K
Receivables $2.858M $65.58K $65.58K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.127M $821.2K $821.2K
YoY Change 540.18% 34.81% 34.81%
LONG-TERM ASSETS
Property, Plant & Equipment $2.604M $2.647M $2.647M
YoY Change 6416.76% 5650.52% 3.39%
Goodwill
YoY Change
Intangibles $2.601M $2.647M
YoY Change -0.25% 3.39%
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $3.536M $3.446M $3.446M
YoY Change 6.94% 5.1% 5.1%
TOTAL ASSETS
Total Short-Term Assets $4.127M $821.2K $821.2K
Total Long-Term Assets $3.536M $3.446M $3.446M
Total Assets $7.663M $4.268M $4.268M
YoY Change 93.96% 9.75% 9.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $519.5K $429.5K $429.5K
YoY Change 29.7% -3.53% -3.53%
Accrued Expenses $226.8K $204.8K $204.8K
YoY Change 22.56% 24.06% 24.06%
Deferred Revenue
YoY Change
Short-Term Debt $400.3K $597.4K $597.4K
YoY Change -31.45% 396.77% 396.77%
Long-Term Debt Due $32.64K $40.14K $40.14K
YoY Change -29.64% -13.47% -13.47%
Total Short-Term Liabilities $1.820M $1.371M $1.371M
YoY Change 31.46% 69.66% 69.65%
LONG-TERM LIABILITIES
Long-Term Debt $126.9K $131.2K $131.2K
YoY Change -9.13% -8.86% -8.86%
Other Long-Term Liabilities $17.39K $14.70K $14.70K
YoY Change 44.8% 59.44% 59.44%
Total Long-Term Liabilities $144.3K $145.9K $145.9K
YoY Change -4.86% -4.75% -4.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.820M $1.371M $1.371M
Total Long-Term Liabilities $144.3K $145.9K $145.9K
Total Liabilities $2.313M $1.517M $2.862M
YoY Change 50.61% 57.8% 26.46%
SHAREHOLDERS EQUITY
Retained Earnings -$3.650M -$4.335M
YoY Change -8.29% 34.18%
Common Stock $33.36K $21.13K
YoY Change 125.36% 48.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.725M $1.406M $1.406M
YoY Change
Total Liabilities & Shareholders Equity $7.663M $4.268M $4.268M
YoY Change 93.96% 9.75% 9.75%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $922.3K -$128.0K -$1.103M
YoY Change -379.31% -83.2% -36.6%
Depreciation, Depletion And Amortization $3.470K $19.03K $159.1K
YoY Change -94.26% -72.26% -42.05%
Cash From Operating Activities -$1.547M -$244.9K -$468.1K
YoY Change 4705.72% -90.3% -82.2%
INVESTING ACTIVITIES
Capital Expenditures $87.70K $95.60K $269.8K
YoY Change -231.88% -209.51% -192.09%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$87.70K -$95.60K -$269.8K
YoY Change 31.88% -107.54% -125.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $414.2K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.622M 359.2K $909.2K
YoY Change -2631.81% -73.34% -44.55%
NET CHANGE
Cash From Operating Activities -1.547M -244.9K -$468.1K
Cash From Investing Activities -87.70K -95.60K -$269.8K
Cash From Financing Activities 1.622M 359.2K $909.2K
Net Change In Cash -12.78K 18.76K $171.3K
YoY Change -92.15% -78.99% 140.97%
FREE CASH FLOW
Cash From Operating Activities -$1.547M -$244.9K -$468.1K
Capital Expenditures $87.70K $95.60K $269.8K
Free Cash Flow -$1.635M -$340.5K -$738.0K
YoY Change -4864.38% -86.03% -68.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001722731
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 FDCT Original Issue Discount Promissory Note
OriginalIssueDiscountPromissoryNote
usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q4 FDCT Cares Act Paycheck Protection Program Advance Noncurrent
CaresActPaycheckProtectionProgramAdvanceNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 FDCT Subscription Receivable
SubscriptionReceivable
usd
CY2021 FDCT Increase Decrease In Original Issue Discount Promissory Note
IncreaseDecreaseInOriginalIssueDiscountPromissoryNote
usd
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2021 FDCT Payments Forex Gain Loss On Consolidation
PaymentsForexGainLossOnConsolidation
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2019 FDCT Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Became Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsBecameExercisable
shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2019Q4 FDCT Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisable
shares
CY2021Q4 FDCT Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
usd
CY2021Q4 FDCT Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
usd
CY2021Q4 FDCT Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
usd
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
usd
CY2022Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
usd
CY2021Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56338
CY2022 dei Entity Registrant Name
EntityRegistrantName
FDCTECH, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1265459
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Spectrum Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
CY2022 dei City Area Code
CityAreaCode
(877)
CY2022 dei Local Phone Number
LocalPhoneNumber
445-6047
CY2022 dei Security12b Title
Security12bTitle
Common
CY2022 dei Trading Symbol
TradingSymbol
FDCT
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
2746582 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
333584729 shares
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash
Cash
264829 usd
CY2021Q4 us-gaap Cash
Cash
93546 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
137371 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
117487 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65583 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21153 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
435814 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
494470 usd
CY2022Q4 FDCT Original Issue Discount Promissory Note
OriginalIssueDiscountPromissoryNote
55000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
821226 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
609169 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
761642 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
650862 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38059 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46024 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2646615 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2559739 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22500 usd
CY2022Q4 us-gaap Assets
Assets
4267542 usd
CY2021Q4 us-gaap Assets
Assets
3888293 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
429500 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
445215 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
47369 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
39246 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
204828 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
165108 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
81000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
550000 usd
CY2022Q4 FDCT Cares Act Paycheck Protection Program Advance Current
CaresActPaycheckProtectionProgramAdvanceCurrent
40139 usd
CY2021Q4 FDCT Cares Act Paycheck Protection Program Advance Current
CaresActPaycheckProtectionProgramAdvanceCurrent
46393 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
99488 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31339 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1371324 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
808301 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
131194 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
139699 usd
CY2021Q4 FDCT Cares Act Paycheck Protection Program Advance Noncurrent
CaresActPaycheckProtectionProgramAdvanceNoncurrent
4239 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
14704 usd
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
9224 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1517222 usd
CY2021Q4 us-gaap Liabilities
Liabilities
961464 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
400 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
400 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211275550 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
211275550 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141811264 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141811264 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
21127 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
14181 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5725530 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4841545 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6169 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4335053 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3230679 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1405835 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1625448 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1344485 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1301382 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4267542 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3888293 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6453732 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
457661 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5434792 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
419884 usd
CY2022 us-gaap Gross Profit
GrossProfit
1018940 usd
CY2021 us-gaap Gross Profit
GrossProfit
42277 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1679121 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1127503 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
382864 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
648833 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2061985 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
1776337 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1043045 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1734059 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
61533 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
11564 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
204 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8929 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61329 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2635 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1104374 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1736695 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1104374 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1736695 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1360 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3202 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1103014 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1739897 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158048019 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86063490 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1038044 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
621000 usd
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.10
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1256908 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services One
StockIssuedDuringPeriodValueIssuedForServicesOne
350000 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services Two
StockIssuedDuringPeriodValueIssuedForServicesTwo
437500 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services Three
StockIssuedDuringPeriodValueIssuedForServicesThree
21000 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services Four
StockIssuedDuringPeriodValueIssuedForServicesFour
22000 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services Five
StockIssuedDuringPeriodValueIssuedForServicesFive
98253 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200000 usd
CY2021 FDCT Stock Issued During Period Value Issued For Financing Cost
StockIssuedDuringPeriodValueIssuedForFinancingCost
80400 usd
CY2021 FDCT Shares Cancelled For Service
SharesCancelledForService
-437500 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services Six
StockIssuedDuringPeriodValueIssuedForServicesSix
164250 usd
CY2021 FDCT Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
25300 usd
CY2021 FDCT Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
37075 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1354500 usd
CY2021 FDCT Stock Issued During Period Value Issued For Services Seven
StockIssuedDuringPeriodValueIssuedForServicesSeven
169500 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1736695 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1625448 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1625448 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
31250 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
93750 usd
CY2022 FDCT Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
25000 usd
CY2022 FDCT Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
20385 usd
CY2022 FDCT Stock Issued During Period Value Issued For Financing Cost
StockIssuedDuringPeriodValueIssuedForFinancingCost
71521 usd
CY2022 FDCT Stock Issued During Period Value New Issues Three
StockIssuedDuringPeriodValueNewIssuesThree
17800 usd
CY2022 FDCT Stock Issued During Period Value New Issues Four
StockIssuedDuringPeriodValueNewIssuesFour
19750 usd
CY2022 FDCT Stock Issued During Period Value Issued For Services One
StockIssuedDuringPeriodValueIssuedForServicesOne
9475 usd
CY2022 FDCT Forex Gain Loss On Consolidation
ForexGainLossOnConsolidation
-6169 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
414185 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
262374 usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-81000 usd
CY2022 FDCT Stock Issued During Period Value New Issues Five
StockIssuedDuringPeriodValueNewIssuesFive
300000 usd
CY2022 FDCT Stock Issued During Period Value Issued For Services Two
StockIssuedDuringPeriodValueIssuedForServicesTwo
60000 usd
CY2022 FDCT Stock Issued During Period Value Issued For Services Three
StockIssuedDuringPeriodValueIssuedForServicesThree
166000 usd
CY2022 FDCT Stock Issued During Period Value Issued For Services Four
StockIssuedDuringPeriodValueIssuedForServicesFour
76000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1104374 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1405835 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1405835 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1104374 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1736695 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
159051 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
274462 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
476746 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1526404 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
19884 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21526 usd
CY2021 FDCT Subscription Receivable
SubscriptionReceivable
200000 usd
CY2022 FDCT Acquired Intangible Asset
AcquiredIntangibleAsset
-7965 usd
CY2021 FDCT Acquired Intangible Asset
AcquiredIntangibleAsset
46024 usd
CY2022 FDCT Acquired Intangible Assets
AcquiredIntangibleAssets
86876 usd
CY2021 FDCT Acquired Intangible Assets
AcquiredIntangibleAssets
2559739 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
64314 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26138 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15715 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
328715 usd
CY2022 FDCT Increase Decrease In Original Issue Discount Promissory Note
IncreaseDecreaseInOriginalIssueDiscountPromissoryNote
-55000 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
68149 usd
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
31339 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-81156 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
289092 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5480 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5368 usd
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
39720 usd
CY2021 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
39721 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-468129 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2630152 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
269831 usd
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
293000 usd
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
1354500 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-269831 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1061500 usd
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
8123 usd
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
175 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
550000 usd
CY2022 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
-18999 usd
CY2021 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
-5201 usd
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
81000 usd
CY2022 FDCT Payment To Minority Shareholders
PaymentToMinorityShareholders
-43103 usd
CY2021 FDCT Payment To Minority Shareholders
PaymentToMinorityShareholders
-1301382 usd
CY2022 FDCT Payments Forex Gain Loss On Consolidation
PaymentsForexGainLossOnConsolidation
6169 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
909243 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1639731 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
171283 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71079 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93546 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22467 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
264829 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93546 usd
CY2021Q4 us-gaap Cash
Cash
93546 usd
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zD7zvE7kMii4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zibPUY0CPHU6">Consolidated Financial Statement Preparation and Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company prepared the consolidated financial statements according to accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Estimates include revenue recognition, the allowance for doubtful accounts, website and internal-use software development costs, recoverability of intangible assets with finite lives, and other long-lived assets. Actual results could materially differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264829 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93546 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
137371 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
117487 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
19884 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21526 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
382864 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
648833 usd
CY2017 FDCT Proceeds From Sale Of Source Code
ProceedsFromSaleOfSourceCode
160000 usd
CY2017 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
160000 usd
CY2017 FDCT Software Developments Revenue Wroteoff
SoftwareDevelopmentsRevenueWroteoff
18675 usd
CY2022 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The Company receives $75 per hour for the first 100 hours/month of approved development services and $45 per hour for all services over 100 hours per month.
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zDMhbVWSDZBa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zJlELoPgRbW1">Concentrations of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cash</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with three months or less of original maturities. The Company maintains its cash balances at a single financial institution. The balances do not exceed Federal Deposit Insurance Corporation (FDIC) limits as of December 31, 2021. On December 31, 2022, and 2021, the Company had $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zY0aDUDjPJt1" title="Cash on hand">264,829</span> and $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_zTmUajrv9Lc9" title="Cash on hand">93,546</span> cash and cash equivalent held at the financial institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Revenues</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending December 31, 2022, and 2021, the Company had ten (10) and eight (8) active customers. Revenues generated from the top three (3) customers represented approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zsIIs3BkGCG4" title="Sales percentage">81.01</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zZ2d5KEfqnV4" title="Sales percentage">52.98</span>% of total revenue for the fiscal year ending December 31, 2022, and 2021 respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Accounts Receivable</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, and 2021, the company’s top four (4) customers comprise roughly <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zcBAz3mnKBKh" title="Concentration risk percentage">89.85</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_znMt8hlzvcjc" title="Concentration risk percentage">100.00</span>% of total A/R, respectively. The loss of any of the top four (4) customers would significantly impact the Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264829 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93546 usd
CY2022 us-gaap Payments For Rent
PaymentsForRent
25438 usd
CY2021 us-gaap Payments For Rent
PaymentsForRent
29705 usd
CY2020Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
From February 2020, this agreement continues every year upon written request by the Company. The Company uses the office for sales and marketing in Europe and Asia
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11M
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
500 usd
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1M
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14703 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1800 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9224 usd
CY2021Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
260000000 shares
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
159051 usd
CY2021 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
274462 usd
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
97996 usd
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
97996 usd
CY2022Q1 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.382 pure
CY2022Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.391 pure
CY2022Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.436 pure
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.522 pure
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158048019 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86063490 shares
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zrpUVg9uFCZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zPotTrU4FKpa">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these classifications impacted reported operating or net loss for any presented period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q1 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
2646615 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4335053 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3230679 usd
CY2022Q4 FDCT Working Capital Deficit
WorkingCapitalDeficit
541359 usd
CY2021Q4 FDCT Working Capital Deficit
WorkingCapitalDeficit
199132 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1104374 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1736695 usd
CY2022Q4 us-gaap Cash
Cash
264829 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211275550 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
211275550 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141811264 shares
CY2021 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1586989 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1317158 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
825347 usd
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
666296 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
761642 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
650862 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
22503 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
47369 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
39246 usd
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1000000 usd
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
256908 usd
CY2019Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1000000 usd
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
196908 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141811264 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2017Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
1000000 shares
CY2017Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
50000 usd
CY2019Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
33000 shares
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
4950 usd
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2967000 shares
CY2022Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
30000000 shares
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
300000 usd
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
653332 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.30
CY2018Q4 FDCT Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisable
653332 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
653332 shares
CY2019 FDCT Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Expiration Date Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDateDescription
April 2019
CY2022Q4 FDCT Deferred Tax Assets Income Loss Per Books M One Difference
DeferredTaxAssetsIncomeLossPerBooksMOneDifference
-1104374 usd
CY2022Q4 FDCT Deferred Tax Liabilities Income Loss Per Books M One Difference
DeferredTaxLiabilitiesIncomeLossPerBooksMOneDifference
-231919 usd
CY2021Q4 FDCT Deferred Tax Assets Income Loss Per Books M One Difference
DeferredTaxAssetsIncomeLossPerBooksMOneDifference
-1736695 usd
CY2021Q4 FDCT Deferred Tax Liabilities Income Loss Per Books M One Difference
DeferredTaxLiabilitiesIncomeLossPerBooksMOneDifference
-364706 usd
CY2022Q4 FDCT Deferred Tax Assets Stock Options Issued For Services
DeferredTaxAssetsStockOptionsIssuedForServices
476746 usd
CY2022Q4 FDCT Deferred Tax Liabilities Stock Options Issued For Services
DeferredTaxLiabilitiesStockOptionsIssuedForServices
100117 usd
CY2021Q4 FDCT Deferred Tax Assets Stock Options Issued For Services
DeferredTaxAssetsStockOptionsIssuedForServices
1526404 usd
CY2021Q4 FDCT Deferred Tax Liabilities Stock Options Issued For Services
DeferredTaxLiabilitiesStockOptionsIssuedForServices
320545 usd
CY2022Q4 FDCT Deferred Tax Asset Depreciation And Amortization
DeferredTaxAssetDepreciationAndAmortization
159051 usd
CY2022Q4 FDCT Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
33401 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
468577 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
98401 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
210291 usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
44161 usd
CY2022Q4 FDCT Deferred Tax Assets Prior Year Nol
DeferredTaxAssetsPriorYearNOL
-888734 usd
CY2022Q4 FDCT Deferred Tax Liabilities Prior Year Nol
DeferredTaxLiabilitiesPriorYearNOL
-186634 usd
CY2021Q4 FDCT Deferred Tax Assets Prior Year Nol
DeferredTaxAssetsPriorYearNOL
-678443 usd
CY2021Q4 FDCT Deferred Tax Liabilities Prior Year Nol
DeferredTaxLiabilitiesPriorYearNOL
-142473 usd
CY2022Q4 FDCT Deferred Tax Assets Cumulative Nol
DeferredTaxAssetsCumulativeNOL
-1357311 usd
CY2022Q4 FDCT Deferred Tax Liabilities Cumulative Nol
DeferredTaxLiabilitiesCumulativeNOL
-285035 usd
CY2021Q4 FDCT Deferred Tax Assets Cumulative Nol
DeferredTaxAssetsCumulativeNOL
-888734 usd
CY2021Q4 FDCT Deferred Tax Liabilities Cumulative Nol
DeferredTaxLiabilitiesCumulativeNOL
-186634 usd
CY2022Q4 FDCT Deferred Tax Assets Operating Loss Carryforward
DeferredTaxAssetsOperatingLossCarryforward
-285035 usd
CY2021Q4 FDCT Deferred Tax Assets Operating Loss Carryforward
DeferredTaxAssetsOperatingLossCarryforward
-186634 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
100117 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
320545 usd
CY2022Q4 FDCT Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
33401 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
418553 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
507179 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-231919 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-364706 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
231919 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
364706 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1104374 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1736695 usd
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Act reduces the corporate federal tax rate from a maximum of 35% to a 21% rate for corporations. The rate reduction will take effect on January 1, 2018. Therefore, we have applied the tax rate of 21% to the ending balance of federal deferred tax assets.
CY2022Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
231919 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
231919 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
231919 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
142473 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
4335053 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3230679 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
204828 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd

Files In Submission

Name View Source Status
0001493152-23-012515-index-headers.html Edgar Link pending
0001493152-23-012515-index.html Edgar Link pending
0001493152-23-012515.txt Edgar Link pending
0001493152-23-012515-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
fdct-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
fdct-20221231_def.xml Edgar Link unprocessable
fdct-20221231_lab.xml Edgar Link unprocessable
fdct-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fdct-20221231_cal.xml Edgar Link unprocessable